Heptares Therapeutics Ltd has generated a stabilised form of a GPCR target under a research collaboration with Cubist Pharmaceuticals Inc enabling the start of a drug discovery programme. Cubist works in acute care and is developing antibiotics. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
